ProMIS Neurosciences, Inc. (PMN)
USD 0.56
(-5.68%)
USD 0.56
(-5.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.36 Million | -17.03 Million | -9.28 Million | -3.41 Million | -4.66 Million | -6.34 Million |
| Net Income | -17.5 Million | -18.06 Million | -9.24 Million | -4.44 Million | -5.66 Million | -7.46 Million |
| Depreciation & Amortization | 28.03 Thousand | 11.21 Thousand | 45.68 Thousand | 12.33 Thousand | 6553.01 | 4898.57 |
| Deferred income taxes | -4.96 Billion | - | 661.94 Thousand | 1.96 | - | 0.88 |
| Stock-based compensation | 359.78 Thousand | 487.63 Thousand | 515.62 Thousand | 205.35 Thousand | 495.6 Thousand | 789.21 Thousand |
| Change in working capital | -2.67 Million | 5.4 Million | -1.55 Million | 688.1 Thousand | 498.08 Thousand | 324.32 Thousand |
| Other non-cash items | 5.42 Million | -4.87 Million | 364.91 Thousand | 119.71 Thousand | 1.02 | - |
| Investing Cash Flow | -1787.38 | -1981.00 | 94.33 Thousand | -87.73 Thousand | -159.23 | -151.98 |
| Investments in PPE | - | -1981.00 | -6025.79 | -85.21 Thousand | - | - |
| Acquisitions | - | - | 2352.90 | -2352.65 | - | - |
| Investment purchases | -32.35 Million | -31 Thousand | -33 Thousand | -32.96 Thousand | -32.01 Thousand | -30.55 Thousand |
| Sales/Maturities of investments | 31 Million | 31 Thousand | 32.96 Thousand | 32.8 Thousand | 31.86 Thousand | 30.4 Thousand |
| Other Investing Activities | -1787.38 | - | 98.03 Thousand | 0.59 | 0.18 | 0.88 |
| Financing Cash Flow | 23.51 Million | 6.49 Million | 25.2 Million | 3 Million | 4.1 Million | 6.86 Million |
| Debt repayment | - | - | -6.91 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.64 Million | - | - | - |
| Common Stock Issuance | - | 4.97 Million | 20.01 Million | - | 4.03 Million | 5.54 Million |
| Other Financing Activities | 23.51 Million | 1.52 Million | 6.82 Million | 3.83 Million | 70.81 Thousand | 1.31 Million |
| Accounts receivables | - | - | - | 27.16 Thousand | -19.55 Thousand | - |
| Accounts payables | 4.96 Billion | 2.67 Million | -31.55 Thousand | 72.78 Thousand | 572.7 Thousand | 331.43 Thousand |
| Inventory | - | - | - | -30.28 Thousand | - | - |
| Other working capital | -2.67 Million | 2.72 Million | -1.52 Million | 618.44 Thousand | -74.61 Thousand | -7111.00 |
| Cash at beginning of period | 7.95 Million | 16.94 Million | 807.02 Thousand | 1.3 Million | 1.82 Million | 1.24 Million |
| Cash at end of period | 16.69 Million | 5.87 Million | 16.81 Million | 806.93 Thousand | 1.27 Million | 1.75 Million |
| Capital Expenditure | - | -1981.00 | -6025.79 | -85.21 Thousand | - | - |
| Effect of forex changes on cash | -240.38 Thousand | -526.89 Thousand | 1.28 | - | - | - |
| Net cash flow / Change in cash | 8.73 Million | -11.06 Million | 16.01 Million | -496.2 Thousand | -557.26 Thousand | 513.86 Thousand |
| Free Cash Flow | -14.36 Million | -17.03 Million | -9.29 Million | -3.5 Million | -4.66 Million | -6.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.62 Million | -3.63 Million | -3.58 Million | -17.5 Million | -2.36 Million | -2.31 Million |
| Depreciation & Amortization | - | - | 18.02 Thousand | 28.03 Thousand | 345.00 | 1238.00 |
| Deferred income taxes | - | - | -579.81 Thousand | -4.96 Billion | - | -551.03 Thousand |
| Stock-based compensation | 17.99 Thousand | 63.58 Thousand | 6415.50 | 359.78 Thousand | - | 134.19 Thousand |
| Change in working capital | 1.19 Million | -6.73 Million | -57.42 Thousand | -2.67 Million | 60.6 Thousand | 675.33 Thousand |
| Other non-cash items | -649.87 Thousand | 6.51 Million | 569.33 Thousand | 5.42 Million | -76.76 Thousand | -95.08 Thousand |
| Investing Cash Flow | - | - | -1336.79 | -1787.38 | -76.78 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -32.06 Thousand | -32.35 Million | - | - |
| Sales/Maturities of investments | - | - | 30.72 Thousand | 31 Million | - | - |
| Other Investing Activities | - | - | -1787.38 | -1787.38 | - | - |
| Financing Cash Flow | -1346.52 | 190.27 Thousand | -748.01 Thousand | 23.51 Million | 18.33 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -676.54 Thousand | - | - | - |
| Common Stock Issuance | -1346.52 | 190.27 Thousand | -748.01 Thousand | - | 18.33 Million | - |
| Other Financing Activities | - | 257.73 Thousand | 17.74 Billion | 23.51 Million | 24.8 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 652.81 Thousand | -6.43 Million | -543.76 Thousand | 4.96 Billion | 623.91 Thousand | 812.89 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 546.86 Thousand | -294.53 Thousand | 486.34 Thousand | -2.67 Million | -563.3 Thousand | -137.55 Thousand |
| Cash at beginning of period | 2.49 Million | 12.59 Million | 16.86 Million | 7.95 Million | 1.22 Million | 3.33 Million |
| Cash at end of period | 992.46 Thousand | 2.49 Million | 12.59 Million | 16.69 Million | 16.86 Million | 1.22 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 109.46 Thousand | -240.38 Thousand | -237.26 Thousand | 38.18 Thousand |
| Net cash flow / Change in cash | -1.5 Million | -10.1 Million | -4.27 Million | 8.73 Million | 15.64 Million | -2.1 Million |
| Free Cash Flow | -1.42 Million | -10.29 Million | -3.63 Million | -14.36 Million | -2.37 Million | -2.14 Million |
BSL
JNPKF
GBFH
KEYCORP
301498
IE